Duloxetine-related posterior reversible encephalopathy syndrome: A case report

about

Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review.

P2860

Q47573159-BE2AFAA3-F5FC-4BF6-8140-E0B3CC8345F3

P2860

Duloxetine-related posterior reversible encephalopathy syndrome: A case report

Item

http://www.wikidata.org/entity/Q37726727

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Duloxetine-related posterior reversible encephalopathy syndrome: A case report

@en

Duloxetine-related posterior reversible encephalopathy syndrome: A case report.

@nl

type

Item

label

Duloxetine-related posterior reversible encephalopathy syndrome: A case report

@en

Duloxetine-related posterior reversible encephalopathy syndrome: A case report.

@nl

prefLabel

Duloxetine-related posterior reversible encephalopathy syndrome: A case report

@en

Duloxetine-related posterior reversible encephalopathy syndrome: A case report.

@nl

P1476

Duloxetine-related posterior reversible encephalopathy syndrome: A case report

@en

P2093

Alexandre Muret

http://www.w3.org/2001/XMLSchema#string

Andrei Girbovan

http://www.w3.org/2001/XMLSchema#string

Catherine Palette

http://www.w3.org/2001/XMLSchema#string

Fabien Marquion

http://www.w3.org/2001/XMLSchema#string

Fernando Pico

http://www.w3.org/2001/XMLSchema#string

François Perier

http://www.w3.org/2001/XMLSchema#string

Nathalie Zappella

http://www.w3.org/2001/XMLSchema#string

Sybille Merceron

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular, pharmacological and functional diversity of 5-HT receptors

Neurological complications of psychiatric drugs: clinical features and management

A reversible posterior leukoencephalopathy syndrome

Determinants of recovery from severe posterior reversible encephalopathy syndrome

Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases.

Serotonin syndrome. Presentation of 2 cases and review of the literature.

The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity.

The SSRI discontinuation syndrome.

P304

e4556

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1097/MD.0000000000004556

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stéphane Legriel

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27537580

http://www.w3.org/2001/XMLSchema#string

P932

5370806

http://www.w3.org/2001/XMLSchema#string

Duloxetine-related posterior reversible encephalopathy syndrome: A case report

about

P2860

P2860

Duloxetine-related posterior reversible encephalopathy syndrome: A case report

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932